Navigation Links
Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
Date:8/29/2007

BOCA RATON, Fla., Aug. 29 /PRNewswire/ -- Dawson James Securities, a full- service investment firm serving the healthcare and biotechnology industry, initiated research coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy rating and a 12-18 month price target of $6.00. John M. Putnam, Sr. VP-Medical Devices, issued the report.

The report describes CryoCor's recently FDA-approved cryoablation system for atrial flutter and their current pivotal trial for atrial fibrillation. Mr. Putnam states "With the FDA's approval of CryoCor's cryoablation system for the treatment of atrial flutter, and the strong prospect of an approval for treating the much larger indication of atrial fibrillation in 2008, we believe the company is on the verge of meaningful revenue generation."

A copy of the report may be obtained by contacting Dawson James Securities at 561-391-5555.

About Dawson James Securities:

Dawson James Securities is a full service investment firm with deep expertise in healthcare and biotechnology and having a staff of over 50 investment professionals providing institutional research, investment banking and high net worth services to our clients. More information is available at http://www.DawsonJames.com

Disclosures:

Dawson James has not acted as an investment banker for the company mentioned in this report in the past, although Dawson James may have sought in the past, or may actively seek in the future, compensation for investment banking services. Dawson James and/or its directors and employees may own securities in the companies and may increase or decrease holdings in the future.

The analyst certifies that 1) all o
'/>"/>

SOURCE Dawson James Securities
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. State puts up $1 million for James Thomsons new stem cell startup
3. OpGen adds Thomas Pyle and James Ogle to board of directors
4. UW stem-cell team led by James Thomson gets $1.25M private grant
5. James Thomson plans to stay in Madison to study genesis of stem cells
6. Early Stage, Step 9: Raising capital in the securities landscape
7. Securities compliance is part of raising capital
8. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
9. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
10. Control Your siRNA Research
11. Getting Started with MicroRNA Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... AUSTIN, Texas , Dec. 23, 2014 /PRNewswire/ ... solutions company focused on gynecologic disease, announced today ... W. Schuler , Birchview Fund LLC and several ... million of unregistered shares of Vermillion,s common stock ... common stock in a private placement.  ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 /PRNewswire/ ... study of mazindol in children with attention deficit/hyperactivity disorder ... December 2014 . The paper, titled ... attention deficit/hyperactivity disorder" ( Konofal et al, ... eCollection 2014 ) shows that mazindol might be ...
(Date:12/22/2014)... CHAPEL HILL, N.C. , Dec. 22, 2014 ... ALNE) today announced that it has signed a ... biotechnology company that has developed and patented a ... and medical diagnostics products that enable rapid on-site ... and alcohol use/abuse and health issues in an ...
(Date:12/22/2014)... ITRA Global, one of the largest ... real estate, has further expanded its global reach with ... Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman of ... Global / ACORPP (Australian Corporate Property and Projects) , ... property services to a wide range of clients in ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2
... brings new ideas, strategies and experience to Wisconsin , ... the process of closing a Venture Capital (VC) fund called ... in what the firm refers to refer to as the ... a $60-million commitment from the State of Wisconsin ...
... The Defense Advanced Research Projects Agency (DARPA), has awarded Alfalight ... DARPA Super High Efficiency Diode Source (SHEDS) program. ... total award of $5.3 million. , , Alfalight , founded ... contract in an appropriations bill passed by Congress bringing their ...
... Has the Wisconsin Economic Summit run its course? With ... that skeptics and supporters alike will ask about the University ... , ,The best answer, to be fair, is wait-and-see. If ... of what has been accomplished over the past three years ...
Cached Biology Technology:West Coast VC Establishes Midwest Presence in Madison 2West Coast VC Establishes Midwest Presence in Madison 3West Coast VC Establishes Midwest Presence in Madison 4West Coast VC Establishes Midwest Presence in Madison 5Alfalight Gets $3.8M From DARPA - Funding has increased to $8.5 Million 2Wisconsin Economic Summit Aims for a New Lease on Life 2
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition ... individuals. Facial recognition system measures the overall facial ... edges, mouth, and the distance between eyes. Facial ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... with seasonal affective disorder (SAD), starting treatment with an ... of developing depression throughout the fall and winter months, ... Biological Psychiatry, official journal of the Society of Biological ... publisher. , "These are the first systematic studies that ...
... presented at the American College of Neuropsychopharmacology's (ACNP) Annual ... necessary for the development of connections between the brain ... Stanford University through a grant from the National Institutes ... of the development of the human brain and possibly ...
... randomized clinical trials have determined that milk thistle ... have any significant influence on the course of ... or C liver disease. These findings are ... According to the previous studies, milk thistle extracts ...
Cached Biology News:In SAD patients, autumn antidepressants can prevent winter depression 2New study identifies key gene in development of connections between brain and spinal cord 2
... an ~185 kDa protein, corresponding to the ... tyrosine 1248 on SDS-PAGE immunoblots. The affinity ... the non-phosphorylated peptide to remove antibodies that ... protein. In cell lines where EGFR ...
... Cyclin D2 is a G1 cyclin required ... candidate for a proto-oncogene. cyclin D2 ... and/or cdk6. Species Reactivity: Human, Mouse, ... DCS-3.1 MAb is particularly well suited for ...
Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Family: Other Applications: Western Blot...
... Immunogen: ... acids 22-37 SGHKSEEKREKMKRTL Antigen ... G-protein signalling; Antigen Subfamily: ... G-protein signalling Recommended Storage: ...
Biology Products: